UK-based SCM Pharma will open its first U.S. office after appointing industry veteran Thomas J. Puskar as vice president of Business Development in North America. SCM secured its first U.S. client this summer, and has hired Mr. Puskar to promote its specialist sterile fill/finish services among U.S. pharma and biopharma firms. The company can perform cGMP sterile fill of radio-labelled compounds also produces highly potent products such as cytotoxics for both clinical trials supply and small ...